| Autor: |
Boyko, E J, Iravani, A, Silverman, M H, Schelling, D J, Wright, R A |
| Zdroj: |
Antimicrobial Agents and Chemotherapy; April 1990, Vol. 34 Issue: 4 p665-667, 3p |
| Abstrakt: |
We conducted a randomized controlled trial of orally administered amifloxacin versus trimethoprimsulfamethoxazole (TMP-SMX) as treatments of acute uncomplicated urinary tract infection in women. Amifloxacin at a dosage of 200 mg twice a day appeared as safe and effective as TMP-SMX, but amifloxacin at 400 mg twice a day tended to cause adverse events more frequently than did TMP-SMX. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
